ClinicalTrials.gg
CompletedNCT06716762Updated Dec 4, 2024

Open vs. Laparoscopic Surgery for Pediatric Choledochal Cyst

An observational study in Congenital Choledochal Cyst, Pediatric Surgery and Surgical Outcomes, sponsored by In-Jin Jang. Completed at 1 site in Korea, Republic of. Open to participants aged 0 Years to 18 Years. Per ClinicalTrials.gov, last updated 2024-12-04.

Sponsored by In-Jin Jang · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
72
Ages
0 Years to 18 Years
Sex
All
01

Study summary

This is a retrospective cohort study designed to compare the outcomes of open surgery versus laparoscopic surgery in pediatric patients diagnosed with congenital choledochal cyst (CCC). The study includes children who underwent surgery at Guangdong Medical University Affiliated Hospital and Guangzhou Women and Children's Medical Center between January 1, 2010, and September 1, 2024. The aim of this study is to evaluate and compare the surgical outcomes, including surgery duration, intraoperative blood loss, hospital stay, and postoperative complications (e.g., bile leakage and intestinal obstruction), between the two surgical approaches. The data collected from the patient records will be analyzed to identify factors influencing surgical outcomes and to guide future treatment decisions for CCC in pediatric patients.

02

Conditions studied

  • Congenital Choledochal Cyst
  • Pediatric Surgery
  • Surgical Outcomes
  • Open Surgery
  • Laparoscopic Surgery

Browse trials for

Keywords

  • Congenital Choledochal Cys
  • Network Meta-analysis
  • Robotic-assisted Surgery
  • Laparoscopic Surgery
  • Pediatric Surgical Outcomes
03

In context

Choledochal Cyst

22 studies on the registry are indexed under Choledochal Cyst; 10 are open to participants now.

This study's enrollment of 72 is below the median of 400 across 14 observational studies indexed under Choledochal Cyst.

Browse Choledochal Cyst studies →

Lead sponsor

This is the only study on the registry with In-Jin Jang as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of pediatric patients diagnosed with congenital choledochal cyst (CCC) who underwent surgical treatment at Guangdong Medical University Affiliated Hospital and Guangzhou Women and Children's Medical Center between January 1, 2010, and September 1, 2024. The total number of patients included in this study is 72, with 60 patients assigned to the open surgery group (OSG) and 12 patients assigned to the laparoscopic surgery group (LSG).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Pediatric patients diagnosed with congenital choledochal cyst based on preoperative imaging (e.g., ultrasound, computed tomography(CT), or magnetic resonance cholangiopancreatography(MRCP)).

Patients who underwent either open surgery (open cyst excision and Roux-en-Y hepaticojejunostomy) or laparoscopic surgery (laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy) for the treatment of congenital choledochal cyst.

for follow-up obtained from the patient's family or legal guardian.

Exclusion criteria

Exclusion Criteria:

Patients lacking one or more key outcome measures, including surgery duration, hospital stay, intraoperative blood loss, incidence of postoperative bile leakage, or incidence of postoperative intestinal obstruction.

Patients with incomplete clinical data, such as missing sex, age, or other essential demographic information.

Patients with coagulation disorders that may interfere with surgery or recovery.

Patients with severe comorbidities or immune system disorders that may complicate surgical intervention or recovery.

Patients who underwent non-surgical treatment (e.g., endoscopic procedures) for congenital choledochal cyst.

Pregnant patients or those who are breastfeeding (if applicable to your study population).

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
72 participants (actual)
Patient registry
No

Groups and cohorts

  • Open Surgery Group, OSG

    This group consists of pediatric patients diagnosed with congenital choledochal cyst (CCC) who underwent open surgery, which involved open cyst excision and Roux-en-Y hepaticojejunostomy. A total of 60 patients were assigned to this group.

    Procedure: Open Surgery

  • Laparoscopic Surgery Group, LSG

    This group includes pediatric patients diagnosed with CCC who underwent laparoscopic surgery, which involved laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy. A total of 12 patients were assigned to this group.

    Procedure: Laparoscopic Surgery

Interventions

  • ProcedureOpen Surgery

    Open cyst excision and Roux-en-Y hepaticojejunostomy performed through a 10 cm incision

  • ProcedureLaparoscopic Surgery

    Laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy performed through small incisions with a laparoscope

06

What researchers measure

Primary outcomes

  1. Surgery Duration

    The time required to complete the surgical procedure, from the initial incision to the closure of the surgical site. This is measured in minutes and compared between the open surgery and laparoscopic surgery groups

    Time frame: Measured intraoperatively, from the initial incision to the closure of the surgical site, at the end of the surgery.

  2. Postoperative Complications

    The occurrence of postoperative complications, specifically bile leakage and intestinal obstruction, in patients undergoing either open or laparoscopic surgery. This is measured as a binary outcome (yes/no) and will be compared between the two groups.

    Time frame: 30 days post-surgery (for short-term complications)

  3. Intraoperative Blood Loss

    The total amount of blood lost during the surgical procedure, measured in milliliters (mL). This will be compared between the two surgical groups (open surgery and laparoscopic surgery).

    Time frame: Measured intraoperatively, during the surgery, from the initial incision to the closure of the surgical site.

  4. Hospital Stay

    The total number of days the patient stays in the hospital post-surgery until discharge. This is compared between the open surgery and laparoscopic surgery groups.

    Time frame: Measured from the day of surgery to discharge, assessed over the duration of hospital stay, up to 30 days post-surgery.

07

Study locations

1 site
  • Hansung University
    Seoul, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06716762
Lead sponsor
In-Jin Jang
Collaborators
Affiliated Hospital of Guangdong Medical University
Responsible party
In-Jin Jang (Professor, Hansung University) — Sponsor-investigator
First posted
Dec 4, 2024
Start date
Jan 1, 2010
Primary completion
Sep 1, 2024
Completion
Nov 1, 2024
Last update
Dec 4, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion